Arterial baroreflex dysfunction fails to mimic Parkinson's disease in rats

Journal of Pharmacological Sciences

Volumn 108, Issue 1, 2008, Pages 56-62

  Yu, Jian Guang ^a   Wu, Jian ^a   Shen, Fu Ming ^a   Cai, Guo Jun ^a   Liu, Jian Guo ^a   Su, Ding Feng ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Arterial baroreflex; Baroreflex sensitivity; Blood pressure variability; Parkinson's disease; Sinoaortic denervation

Indexed keywords

DOPAMINE; OXIDOPAMINE; ROTENONE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIAL BAROREFLEX DYSFUNCTION; ARTICLE; BLOOD PRESSURE VARIABILITY; CATALEPSY; CONTROLLED STUDY; CORPUS STRIATUM; EXPLORATORY BEHAVIOR; MALE; MICROINJECTION; MOTOR DYSFUNCTION; NONHUMAN; OSMOTIC MINIPUMP; PARKINSON DISEASE; PATHOGENESIS; PRESSORECEPTOR REFLEX; RAT; REARING; SUBSTANTIA NIGRA;

EID: 52949091461     PISSN: 13478613     EISSN: 13478648     Source Type: Journal    
DOI: 10.1254/jphs.08144FP     Document Type: Article

References (33)

1. Miao CY, Cai GJ, Tao X, Xie HH, Su DF. Greater hypertrophy in right than left ventricles is associated with pulmonary vasculopathy in sinoaortic-denervated Wistar-Kyoto rats. Clin Exp Pharmacol Physiol. 2004;31:450-455.
2. Shen FM, Zhang SH, Xie HH, Jing Q, Wang DS, Su DF. Early structural changes of aortic wall in sinoaortic-denervated rats. Clin Exp Pharmacol Physiol. 2006;33:358-363.
3. Gu XW, Xie HH, Wang J, Shen FM, Su DF. Arterial baroreflex is not involved in salt preference in rats. Clin Exp Pharmacol Physiol. 2006;33:607-611.
4. Norman RA Jr, Coleman TG, Dent AC. Continuous monitoring of arterial pressure indicates sinoaortic denervated rats are not hypertensive. Hypertension. 1981;3:119-125.
5. La Rovere MT, Bigger JT Jr, Marcus FI, Mortara A, Schwartz PJ. Baroreflex sensitivity and heart-rate variability in prediction of total cardiac mortality after myocardial infarction. ATRAMI (Autonomic Tone and Reflexes After Myocardial Infarction) Investigators. Lancet. 1998;351:478-484.
6. Shen W, Gill RM, Zhang JP, Jones BD, Corbly AK, Steinberg MI. Sodium channel enhancer restores baroreflex sensitivity in conscious dogs with heart failure. Am J Physiol Heart Circ Physiol. 2005;288:H1508-H1514.
7. Liu AJ, Ma XJ, Shen FM, Liu JG, Chen H, Su DF. Arterial baroreflex. A novel target for preventing stroke in rat hypertension. Stroke. 2007;38:1916-1923.
8. Shen FM, Guan YF, Xie HH, Su DF. Arterial baroreflex function determines the survival time in lipopolysaccharide-induced shock in rats. Shock. 2004;21:556-560.
9. Shu H, Ying-Ming W, Xu LP, Miao CY, Su DF. Increased susceptibility of ventricular arrhythmias to aconitine in anaesthetized rats is attributed to the inhibition of baroreflex. Clin Exp Pharmacol Physiol. 2004;31:249-253.
10. Cai GJ, Miao CY, Xie HH, Lu LH, Su DF. Arterial baroreflex dysfunction promotes atherosclerosis in rats. Atherosclerosis. 2005;183:41-47.
11. Singer C, Weiner WJ, Sanchez-Ramos JR. Autonomic dysfunction in men with Parkinson's disease. Eur Neurol. 1992;32:134-140.
12. Zesiewicz TA, Baker MJ, Wahba M, Hauser RA. Autonomic nervous system dysfunction in Parkinson's disease. Curr Treat Options Neurol. 2003;5:149-160.
13. Oka H, Yoshioka M, Onouchi K, Morita M, Mochio S, Suzuki M, et al. Characteristics of orthostatic hypotension in Parkinson's disease. Brain. 2007;130:2425-2432.
14. Goldstein DS. Cardiac denervation in patients with Parkinson disease. Cleve Clin J Med. 2007;74 Suppl 1:91-94.
15. Goldstein DS, Sharabi Y, Karp BI, Bentho O, Saleem A, Pacak K, et al. Cardiac sympathetic denervation preceding motor signs in Parkinson disease. Clin Auton Res. 2007;17:118-121.
16. Paxinos G, Watson C. The rat brain in stereotaxic coordinates. 4th ed. New York: Academic Press; 1998.
17. Miklyaeva EI, Martens DJ, Whishaw IQ. Impairments and compensatory adjustments in spontaneous movement after unilateral dopamine depletion in rats. Brain Res. 1995;681:23-40.
18. Fujisawa M, Miyamoto O, Itano T, Tokuda M, Matsui H, Nagao S, et al. Ceruletide suppresses rotational behavior in lesioned rats via CCKA receptors. Eur J Pharmacol. 1993;238:127-130.
19. Sherer TB, Betarbet R, Greenamyre JT. Chronic subcutaneous rotenone exposure causes highly selective dopaminergic degeneration and alpha-synuclein aggregation. Exp Neurol. 2003;179:9-16.
20. Alam M, Mayerhofer A, Schmidt WJ. The neurobehavioral changes induced by bilateral rotenone lesion in medial forebrain bundle of rats are reversed by L-DOPA. Behav Brain Res. 2004;151:117-124.
21. Srinivasan J, Schmidt WJ. Behavioral and neurochemical effects of noradrenergic depletions with N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine in 6-hydroxydopamine-induced rat model of Parkinson's disease. Behav Brain Res. 2004;151:191-199.
22. Wang J, Shen FM, Zhang XF, Wang MW, Su DF. Functional arterial baroreflex attenuates the effects of antihypertensive drugs in conscious rats. J Pharmacol Sci. 2006;100:271-277.
23. Shen FM, Wang J, Ni CR, Yu JG, Wang WZ, Su DF. Ketanserin-induced baroreflex enhancement in spontaneously hypertensive rats depends on central 5-HT2A receptors. Clin Exp Pharmacol Physiol. 2007;34:702-707.
24. Zhang W, Liu AJ, Yiming W, Liu JG, Shen FM, Su DF. Pressor and non-pressor effects of sodium loading on stroke in stroke-prone spontaneously hypertensive rats. Clin Exp Pharmacol Physiol. 2008;35:83-88.
25. Alexander N, Nakahara D, Ozaki N, Kaneda N, Sasaoka T, Iwata N, et al. Striatal dopamine release and metabolism in sinoaortic-denervated rats by in vivo microdialysis. Am J Physiol. 1988;254:396-399.
26. Spillantini MG, Schmidt ML, Lee VM, Trojanowski JQ, Jakes R, Goedert M. Alpha-synuclein in Lewy bodies. Nature. 1997;388:839-840.
27. Wooten GF. Neurochemistry and neuropharmacology of Parkinson's disease. In: Watts RL, editor. Movement disorders: neurologic principles and practice. New York: McGraw-Hill; 1997.
28. Sherer TB, Betarbet R, Greenamyre JT. Environment, mitochondria, and Parkinson's disease. Neuroscientist. 2002;8:192-197.
29. Betarbet R, Sherer TB, MacKenzie G, Garcia-Osuna M, Panov AV, Greenamyre JT. Chronic systemic pesticide exposure reproduces features of Parkinson's disease. Nat Neurosci. 2000;3:1301-1306.
30. Carman LS, Gage FH, Shults CW. Partial lesion of the substantia nigra: relation between extent of lesion and rotational behavior. Brain Res. 1991;553:275-283.
31. Lu SF, Young HJ, Lin MT. Nigrostriatal dopamine system mediates baroreflex sensitivity in rats. Neurosci Lett. 1995;190: 17-20.
32. Goldstein DS, Eldadah BA, Holmes C, Pechnik S, Moak J, Saleem A, et al. Neurocirculatory abnormalities in Parkinson disease with orthostatic hypotension: independence from levodopa treatment. Hypertension. 2005;46:1333-1339.
33. Goldstein DS, Imrich R, Peckham E, Holmes C, Lopez G, Crews C, et al. Neurocirculatory and nigrostriatal abnormalities in Parkinson disease from LRRK2 mutation. Neurology. 2007;69: 1580-1584.